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Abstract 
The process of invasion is of special importance in cancer metastasis, the main cause of death in cancer patients. Cells typically 
penetrate a matrix by degrading it or by squeezing through pores. However, cell mechanics and forces applied by cells especially 
during the initial stages of metastatic penetration, as metastatic cells indent a substrate, are still unknown. Highly metastatic (high 
MP) breast-cancer cells are internally and externally softer than low MP and benign cells, as a result of cytoskeleton structure and 
intracellular activity. Although the high MP cells are softer they are still able to apply strong forces. It is the combination of 
enhanced pliability and strength of these cells contributes to their invasive capabilities. We show that metastatic breast-cancer 
cells indent, in likely attempted penetration even a non-degradable substrate with sub-micron pores, impenetrable to the cells. We 
visualize indentation through focal depth changes of particles embedded in the impenetrable substrate. Cells develop grip handles 
and pull the underlying gels inwards and upwards and then push the cell body into the indentation concavity. Cells repeatedly 
attempt penetration this way over several hours, and can relocate when penetration is unsuccessful, indicating an advanced 
mechano-transduction feedback loop. More attempts and stronger forces are applied to stiffer gels and by the low and high MP 
cells, surprisingly also resulting in deeper indentations by some of the cells on the stiffer gels. Hence, a single, metastatic cell 
requires substrates to be soft enough to indent, yet stiff enough to generate force on. Our system reveals cell adaptation, force 
application mechanisms, and can potentially serve as a diagnostic and treatment testing platform. 
© 2014 The Authors. Published by Elsevier B.V. 
Peer-review under responsibility of Konstantin Volokh and Mahmood Jabareen. 
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1. Introduction  
Cancer is the uncontrolled growth of abnormal cells in the body. Cells can occasionally mutate due to abnormal 
expression of genes, causing the cells to divide rapidly and/or become immortal. Together with genetic and 
* Corresponding author. Tel.: +972-4-8294134; fax: +972-4-8294599. 
E-mail address: daphnew@tx.technion.ac.il 
 2014 The Authors. Published by Elsevi r B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons. rg/licenses/by-nc-nd/4.0/).
Peer-review under responsibility of Konstantin Volokh and Mahmood Jabareen.
212   Revital Kristal-Muscal et al. /  Procedia IUTAM  12 ( 2015 )  211 – 219 
biochemical changes, cancer cells also undergo mechanical changes. While mechanical measurements on breast 
tumors show they are significantly stiffer than normal tissue,  1,2 single, metastatic, breast cancer cells are typically 
internally and externally softer than normal cells.3-5 The relative softness of a single cancer cell is attributed to 
changes in the cell cytoskeleton, as the amount of constituent polymers and accessory proteins are reduced.3,6,7 The 
cancer cells are also highly adaptable and although a single cell may be relatively soft, we have recently shown that 
they are also able to apply force when an obstacle is encountered.8 The increased pliability, dynamics, and 
adaptability allow cells that are shed from the primary tumor to successfully migrate to distant organs.  
In many types of cancer, the main cause of death is not the primary tumor but its metastases to distant sites 
forming a secondary tumor.9 During this process, cells detach from the primary tumor, invade the blood- or lymph-
system, and use them to move inside the body. Subsequently, those cells can invade a distant location by penetrating 
it, adhering and proliferating - initiating a secondary tumor.10,11 The ability to invade a gel substrate is of special 
importance in cancer metastasis, as the tumor is surrounded by a bio-gel, extracellular matrix (ECM), which is one 
of the first obstacles that a cancer cell encounters on its way to a new location.12 Cell invasion typically requires 
either a degradable environment or pores large enough to traverse.13 Metastatic potential has thus conventionally 
been defined in vitro by counting cancer cells able to cross through Boyden chambers that include non-degradable 
membranes with different mesh or pore size14; cells that are able to cross smaller pores are more invasive. That 
invasion requires cell pliability and in soft gel materials the cells may also apply force to invade. The mechanical 
processes involved in cancer cell invasion, and specifically the role force generation, are currently not well 
understood. 
Here, we review the typical mechanisms involved in metastatic, cancer cell invasion and show results suggesting 
that substrate stiffness is a controlling parameter, affecting invasive capabilities of metastatic cells.8 We describe the 
mechanical elements in the cell and how those are utilized by cells to induce motion and apply force. We discuss 
various accepted invasion mechanisms and how cells accomplish them. We also discuss effects of substrate stiffness 
and how forces applied by cells onto the substrate can be measured. Finally, we provide results showing that 
substrate stiffness affect cell ability to apply force onto it and demonstrate cell adaptability to changing conditions.  
2. Invasion and migration of cancer cells  
Metastasis involves cells invading the surrounding tissue, moving through it or adhering to sites within; that 
process is not unique to tumor cells and is used also by healthy immune-system cells and by cells migrating during 
wound healing in the body.15 Metastatic invasion and migration require activation of signaling pathways that control 
cell cytoskeleton dynamics and the turnover of cell-matrix and cell-cell junctions.11 Activation or over expression of 
signaling pathways such as Rac, Rho, Rho-associated serine/threonine kinase or myosin light-chain kinase have been 
correlated with in vitro cancer cell migration and in vivo invasion.16-19 Cells can migrate as individuals or as a 
multicellular connected group, depending on cell type and the extra-cellular environment. If cell-cell junctions exist, 
the cells will remain adhered and migrate collectively, while absence of junctions results in each cell migrating 
individually.20 Invasion and migration processes require cells to modify their shape and biochemical and mechanical 
interactions with the surrounding cells and tissue. Cells control their shape and interactions through the cytoskeleton 
and its associated molecular motors.  
2.1. Mechanical structure of the cell - the cytoskeleton and associated molecular motors 
The cell is the basic structural and functional unit of all known living organisms. Cells are enclosed units bounded 
by a membrane. The cell interior includes the nucleus, where genetic material is stored, and the cytoplasm, which is 
composed of different structures and organelles each with specific roles and tasks. The cytoplasm is a crowded, 
viscoelastic microenvironment, constantly being regulated to adapt to changing conditions. That tight regulation is 
required to maintain the cell shape and morphology and facilitate cell division, cell motility, and more.21,22 The main 
mechanical structures participating in those fundamental processes is the dynamic cell cytoskeleton and the 
cytoskeleton-associated molecular motors. 
The cytoskeleton includes 3 different types of three-dimensional (3D) bio-polymer protein networks – actin 
filaments, microtubules, and intermediate filaments – each with different roles and dynamic structural remodeling 
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abilities. The cytoskeleton as a whole has three key roles: (i) spatially organize the content of the cell by maintaining 
structure and facilitating intracellular transport; (ii) connect the cell physically and biochemically to the external 
environment, and (iii) generate coordinated forces that enable the cell to move and change shape.23 The actin and 
microtubules are more dynamic, facilitating faster responses while the intermediate filaments mostly provide 
structural support.  
Actin filaments are the most dynamic due to their simple construction and are mainly located near the 
membrane.24 The actin network provides mechanical support to the membrane, interacts with the external cell 
environment through the membrane, produces force required for morphological change and cell motion, and 
provides tracks for transport of intracellular material using motor proteins. Actin filaments are composed of globular 
actin (G-actin) monomers that polymerize spontaneously to form long actin filaments (F-actin) that can be rapidly 
remodeled. Actin filaments can form bundles or stress fibers that are more mechanically stable. The filaments can 
also be cross-linked by myosin family molecular-motors, forming a dynamic and regulated gel-like network 
structure. The interaction between actin and different types of myosin motors facilitates transport along filaments or 
cell motion and force application by network contraction (see section  2.2). Actin interacts with the extracellular 
environment via integrins, which are trans-membrane receptors that form adhesion points with the ECM. 
Microtubules span the cytoplasm, connecting the nucleus and the membrane, and have an essential role in cell 
motility, cell division, organelle transport and cell morphogenesis and organization. Microtubules form when α/β
tubulin heterodimers polymerize to long strands. The heterodimer orientation results in directional polarity of the 
microtubules, defined through plus/minus ends that have structural and kinetic differences. The minus side is located 
near the cell nucleus at a centrosome, while the plus side is peripheral at the cell membrane. The polarity of the 
microtubules is used by specific families of motors, dynein and kinesin, that move to and from the nucleus, 
respectively.25
Intermediate filaments are short, complex structured bio-polymers that form across the cytoplasm; their name is 
due to their diameter being between that of the actin filaments and microtubules. Unlike the actin and microtubules, 
the intermediate filaments are not dynamic and therefore less involved in cell motility and migration. The major 
roles of the intermediate filaments major are assumed to be absorbing mechanical stress and being a binding factor 
for all the cytoskeleton elements.26,27  
2.2. The role of the cytoskeleton in cell motility and force application  
The reduced external and internal stiffness of cancer cells is due to changes in organization of the cytoskeleton 
network. There is a reduction in the well-defined F-actin filaments and stress fibers, especially the sub-membrane 
actin.28 In the internally soft malignant cells, the microtubule cytoskeleton network is sparse and has large voids.5
Those mechanical changes result in a weaker and softer cytoskeletal structure and may facilitate an easy migration 
and invasion of malignant cells during metastasis. 
While all three cytoskeletal elements (actin, microtubules, and intermediate filaments) are involved in cell 
motility and force application, actin has a key role in this process.24 Cells apply force either normal to the membrane 
or parallel to it, respectively, pushing the membrane from within the cell or applying traction to the substrate 
through the membrane. Actin remodeling is used to push the membrane in a process called treadmilling, where G-
actin depolymerizes at the back end of the filament and is added at the leading edge. In contrast, traction force 
application requires the actomyosin network to generate contraction in the cell that is transferred to the ECM that the 
cell is attached to. Specifically, myosin motors connect actin filaments in the network and can move them relative to 
each other. That relative motion will result in contraction of the network in the cell and when the cell is attached to 
the ECM (through integrins) traction forces are applied to the substrate. The internal contractions are used by the 
cell for other processes as well: pinch and divide proliferating cells into two, change cell structure to fit into tissue, 
and pull up the rear end of a crawling cell.  
For cells to crawl or apply force they must first attach to the substrate. Attachment is achieved through the 
integrins connecting the actin to the ECM through the membrane. The extracellular part of the integrins connects to 
ECM proteins, while the intracellular part typically binds to actin and then activates a Rho GTPase signaling 
cascade inside the cell. Rho GTPase activation is influenced by the microtubules that interact with the actin 
filaments, cooperatively affecting the extension of the leading edge of the cell. For example, microtubule shortening 
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at the rear edge of the cell can cause Rho GTPase activation leading to actin contraction, tail detachment, and cell 
motion. Conversely, Rho GTPase can regulate the microtubule and actin assembly and organization during cell 
migration.21
The motion of crawling or invading tumor cells has four major stages: (i) Extension of directed protrusions 
(lamellipodia, filopodia, or pseudopodia) at the leading edge. The force required for this step comes from localized 
polymerization of G-actin into cross-linked networks of F-actin in lamellipodia or bundles of filaments in filopodia 
or pseudopodia; (ii) anchoring of protrusions to the ECM by integrin adhesive complexes (focal adhesions29,30) that 
are sites for force transmission to the substrate; (iii) actomyosin complexes contract, depending on cell type, at the 
front or at the rear of the cell to move the cell body forward, and (iv) release of integrin cell-attachments at the 
rear.31
2.3. Mechanism of single cell motility 
Cell migration results from five interdependent molecular-structural steps that change the cell shape, its 
interactions, and the structure of the tissue through which migration occurs32-34: 
• The cell’s leading edge is extended in the direction of movement, polarizing cell shape, by activation of Rho 
GTPases that increases localized and directional actin polymerization and stress fiber formation.  
• The leading edge protrusion engages with the ECM substrate through integrin-mediated focal contacts on the cell 
membrane that connect to the f-actin stress fibers in the cytoplasm. 
• Several micrometer rearward of the leading edge, cell surface proteases become engaged with extracellular 
scaffold proteins and execute locally controlled proteolysis. That proteolysis modifies the molecular and 
mechanical tissue properties and provides space for the cell body. 
• The small GTPase Rho activates myosin II which contracts f-actin stress fibers in the actomyosin active network, 
generating tension inside the cell. 
• Gradual turnover of adhesion bonds at the trailing edge causes the cell to slide forward while the leading edge 
protrudes further in to the tissue. Disassembly of the f-actin holding the focal complexes at the cell rear and 
subsequent release of cell-ECM contact sites, allow the cell rear to be dragged in the direction of migration. 
Then, membrane adhesion receptors are recycled from the rear to the front of the cell. 
2.4. Single cell invasion and motility modes 
Two modes of 3D motility have been defined for single cancer cells: mesenchymal and amoeboidal,13 breaking 
down (degrade) the ECM or squeezing through its pores, respectively. Migrating tumor cells can convert between 
the two modes under conditions where one of the mechanisms is inhibited.33,35,36 For example, a cell will use 
amoeboid motility when it is unable to disassemble its ECM due to lack of suitable proteolytic agents.35 Both types 
of migration are based on reorganization of the actin cytoskeleton and regulated by Rho family small GTPases, with 
different requirements for Rho and Rac signaling.36
Mesenchymal motility involves proteolysis of the ECM and is characterized by elongated cell morphology. Cells 
adhere to the ECM and form protrusions with high concentration of integrins clusters and high proteases activity 
towards the ECM. The formation of the protrusions at the leading edge is Rac dependent while Rho signaling is not 
essential.36 The cell surface proteases degrade the ECM creating cavities in the ECM through which the cell can then 
migrate.32 Cancer cells originating from all types of tumors can use this mode after undergoing de-differentiation and 
losing their cell-cell junctions.35,37,38
In contrast to the mesenchymal motility, the amoeboid mode does not require degradation of the ECM and the 
cell morphology is usually rounded.13,35 Cells apply actomyosin contractile forces through membrane-protrusions to 
move aside ECM fibers and pull the cell body forward.39 Actomyosin contractility is utilized in one of two methods 
– (i) creating weak adhesive forces of Rac-dependent filopodia with the surrounding substrate36,40 or (ii) generating 
propulsion using either Rho-dominated36 blebs (smooth membrane protrusions) at the leading edge and for lateral 
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interaction. Tumor cells that move in amoeboid motion typically originate from the hematopoietic or 
neuroectodermal systems, yet cell subsets of other tumors also use this mode.3,13
3. Effects of substrate stiffness 
The ECM stiffness induces signal transition into the cell by activating integrins at the focal adhesions sites, which 
generate a cell responce41; concurrently, cells can transmit forces to the ECM through the focal adhesions.42,43
Correspondingly, cells will respond to forces exerted on them by compression or tension of the ECM, fluid-flow 
induced shear-stress, or changes in ECM stiffness.44 Substrate stiffness influences the ability of cells to adhere and 
thus also their ability to invade. For example, fibroblasts generate more traction force and have flatter morphology 
on stiff substrates than they do on soft but equally adhesive surface, and cells will preferentially migrate from soft to 
stiff surfaces.45 Soft substrates are unable to support the required forces for adhesion while stiff substrates causes 
hyper stabilization of adhesion sites, such that cells are unable to move or attempt invasion.46 Therefore, 
intermediate substrate stiffness is required to enable cell motility and invasion.8,47 The critical stiffness depends on 
cell type as well as other biochemical and mechanical cues between the ECM and the cell.  
Most mammalian cells in the body require a substrate to attach to, be it other cells in the tissue or the ECM 
surrounding them. Those have an elastic modulus of 10-10,000 Pa and are locally-2D or 3D in structure46,48; 
dimensionality also significantly affects cell behavior, but is not the focus of the current work. The stiffness of the 
surface to which cells adhere can have a profound mechanical effect on the cell such as changes in its morphology, 
motility, forces developed and protein expression.30,46 Substrate rigidity has been shown to regulate cancer cell 
invasiveness at the primary tumor site.1,45,49 In addition, breast cancer cells exhibit increased proliferation and 
migration through gels with stiffness that corresponds to the native stiffness of the organs where metastasis was 
observed.50 In addition, the composition and density of the ECM can induce a switch between mesenchymal and 
amoeboid motion.35  
3.1. Measuring forces applied by cells on a gel 
Forces applied by adherent and crawling cells on elastic substrates have been measured by methods introduces in 
the last decade. The methods typically include a gel substrate with sub-micron fluorescent particles at it surface51,52
or flexible posts53,54, both with ECM-molecules at their tops to facilitate cell adhesion. The typical 2D gel substrate 
that is used is polyacrylamide (PAA) gel, as it is a synthetic impenetrable gel, that when coated with adhesive 
ligands like collagen or fibronectin, it mimics the mechanical properties of natural tissues in 2D. PAA gels can be 
produced in the range of 100 Pa to100 kPa.45  
As the PAA gels are impenetrable cells are typically only expected to apply lateral forces on them. Those forces 
can be calculated using traction force microscopy (TFM).52 In TFM, pairs of images with and without cells are 
collected, from those strains on the gel are calculated by embedded particle displacement, and are converted into 
traction stress fields.43,52 The substrate deformations are used to statistically compute the most likely traction stress 
field that can obtained from the measured deformation52,55-57; the inverse problem is solved here. These algorithms 
enable calculation of sub-picoNewton scale forces from sub-nanometric displacements; that high sensitivity is 
required when handling cells that exert such small forces.42,58  
Forces applied by cells normal to the substrate require a different calculation approach and specific models. New 
methods have recently been proposed to calculate simultaneously occurring lateral (traction) and normal forces.59,60
The substrate deformation is obtained by imaging a small volume of the elastic substrate with embedded fluorescents 
beads marking its surface location. Similarly to 2D TFM, correlating two images – with and without cells – provides 
the 3D deformation of the substrate due to cell applied forces. The models used in these cells show that the normal 
forces occurred as part of normal cell adherence and together with lateral traction force, usually exhibiting 
indentation depths no greater than 0.5 μm.59,60  
216   Revital Kristal-Muscal et al. /  Procedia IUTAM  12 ( 2015 )  211 – 219 
Fig. 1. Schematic of elastic sphere with radius, Rcell, indenting an elastic gel with Young’s modulus Egel and Poisson ratio υgel to a depth of ΔL. 
In metastatic cancer cells, during the initial stages of cell invasion to a substrate, cell indentation, a much larger 
deformation occurs.8 Therefore, those methods cannot be used to calculate the forces apply by the indenting cells. 
Yet, no mathematical theory was established yet to calculate the normal force applied during metastatic indentation, 
which is likely the initial stages of invasion by cancer cells. To calculate the forces, we have chosen to use the Hertz 
model61 with a spherical shape  for simplicity as a first approximation(see Fig. 1). For an elastic sphere (the cell) 
indenting an elastic substrate (the gel) the Hertz model calculation is:  
( )
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−
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ν
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4. Results – forces applied by single metastatic cells
We monitored the indentation produced by a metastatic breast-cancer cell on soft, flat, polyacrylamide gels with 
200-nm fluorescent particles marking the gel surface; particles are within the gel and unreachable to the cells. We 
used gels with Young’s moduli of 1,250±150 Pa and 2,300±200 Pa, representing physiologically soft tissue.48 As a 
metastatic cell indents the substrate, 3D structural changes are revealed through focal-height changes in the particles 
embedded at the gel surface. That depth-of-indentation allows us to evaluate the applied normal force using the 
Hertz model.61 We compared forces applied by high low metastatic potential (MP) breast cancer cells and benign 
breast cells as control8; cells are MDA-MB-231, MDA-MB-468, and MCF-10A, respectively. While the metastatic 
cells indented the gels, control benign cells remained rounded and did not indent gels at any timescale. To correlate 
the indentation capabilities with the metastatic potential, we modified the highly metastatic cells with trans-retinoic 
acid (TRA); TRA has been shown to reduce in vitro invasive capacity of the cells by 60-65%.62
Most metastatic cells remained rounded on the gel surface and about 15%, 30%, and 25% of cells indented the 
gel in the low MP, high MP, and trans-retinoic acid treated high MP cells, respectively; benign cells did not indent 
substrates at all. Fewer cells adhered on the softer gels and less low MP cells adhered overall. High MP cells were 
observed to relocate on the gels after several hours, repeating indentation attempts at a different location. Indentation 
is detected through location of the fluorescent particles marking the gel surface. We observe a condensed ring of 
particles under the cells which also appears elevated from the gel surface.8 Within that defined margin particles are 
found at a lower focal plane than the gel surface, indicating indentation.  
Using the soft PAA gels, we show that metastatic cells will attempt indentation even through an impenetrable gel, 
given that its stiffness is in the appropriate range.8 We compare high metastatic potential (MP), low MP, and benign 
cells seeded on PAA gels with stiffness of 1-2 kPa. We show that metastatic cells repeatedly indent an impenetrable, 
elastic, soft substrate for several hours. Metastatic cells attained a mushroom like morphology pulling the substrate 
inwards and upwards at grip handles and pushing the cell body to indent the gel. Indentation depths observed here 
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(up to 9 μm) are significantly larger than dimples exhibited by cells that spread59 or crawl60on a substrate (< 0.5 
μm). Those smaller dimples are a consequence of 2D cell adhesion and not due to an actively applied vertical force 
as observed here. The high and low MP cells repeatedly indent the gels over several hours applying alternately 
larger and smaller forces with time (see Fig. 2a&b). As force is not exerted continuously, we define force as a 
function of attempt number. Indentation attempts are defined as local force-maxima observed during the experiment 
time (Fig. 2c). 
Fig. 2d shows that applied force directly correlates with metastatic potential of the cells and stiffness of the gel 
and is affected by drugs.8 We observe that the high MP cells consistently apply more force to the gels than the low 
MP cells; elevated actomyosin generated forces correlate with increased invasiveness in metastatic cells.63 Both 
metastatic cell lines (high and low MP) exhibited stronger forces on the stiffer gels. In the high MP cells forces are 
smaller on the softer gels as compared to the stiffer, as less force is required to achieve the same indentation depth. 
However, for the low MP cells, the penetration depth reduces on the softer gels as does the applied force, likely 
indicating they are not able to grip the gel and develop force as well. Application of trans-retinoic acid, a chemical 
shown to reduce in vitro invasive capacity of the cells by 60–65%,62 significantly reduced the force and the 
indentation depth that high MP cells could apply. 
Fig. 2. Forces applied by representative single-cells. (a) High MP cells on 2300 Pa gel, each line is a single cell; (b) Low MP cells on 2300 Pa 
gel; (c) Number of cell indentation attempts (top) high MP cells attempts on, from left to right, the 1250 Pa (green) and 2300 Pa (red) gels and 
TRA-treated high MP cells on 2300 Pa gel (blue), (bottom) low MP cells. Only cells with at least 5 time-points were counted. T-test shows that 
there is no significant difference in number of indentation attempts between the different cells on the various gels (p=0.01), making it an 
independent parameter appropriate for use as an x-axis; (d) Average peak forces applied as a function of attempt number by the high MP cells 
(■,■), low MP cells (▲,▲) attempts on the 1250 Pa (empty) and 2300 Pa (full) gels, and TRA-treated high MP cells on the 2300 Pa gel (●). 
Error bars are standard errors. T-tests show that differences between forces applied at attempts 1 and 2 are statistically significant (p≤0.01); in 
attempt 3 there was not enough data to verify significance. 
In conclusion, metastatic cells will actively and repeatedly indent a soft gel, although it is non-degradable and 
impenetrable. We show that although the high MP cells are softer internally5 and externally3,4 as compared to low 
MP and non-cancerous cells, they are able to adapt and apply stronger forces indicating an advanced mechano-
transduction feedback loop. Reducing the in vitro invasive capacity of the high MP cells with trans-retinoic acid did 
not affect the number of indentation attempts, yet reduced the indentation depth and force applied by a cell. Hence, 
substrate stiffness is a controlling parameter in indentation ability of cells. Cells develop force more readily on 
stiffer gels, indicating that cells will be more likely to successfully penetrate gels stiff enough to provide grip 
handles yet soft enough to indent.  
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